Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SergeyCYW Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1343459213004173312.png) Sergey [@SergeyCYW](/creator/twitter/SergeyCYW) on x 6351 followers
Created: 2025-04-23 04:06:58 UTC

$ISRG Posts +28% Net Income Growth in Q1’25 — But Shares Dip Slightly
Intuitive Surgical reported another strong quarter.
Net Income climbed +28.2% YoY with Net Margin expanding to 31%, and EPS rose +27.2% YoY to $XXXX. Operating Income jumped +23.2%, supported by margin expansion to 26%, while EBITDA margin held at 31%, signaling durable profitability.

Revenue increased +19.1% YoY to $2.25B, led by +25.0% growth in System sales and a +24.5% YoY rise in Da Vinci placements, reflecting continued momentum in surgical adoption. Recurring revenue also climbed +18.9%, showing strength in platform retention.

Yet despite all of this, shares fell -XXX% post-earnings. Could it be concern around margin trends in Services?

While Product Gross Profit grew +19.3% YoY, Services margin contracted significantly by -XXXX PPs YoY, despite only modest +6.9% growth in Services Gross Profit. That could signal pressure in high-margin service activities.

Valuation remains elevated with EV/Sales at XXXX and Forward P/E at XXXX. With expectations this high, even a strong quarter might not be enough to drive upside without a beat or guidance raise.

Operationally, $ISRG is executing well. The question is whether market sentiment can keep pace with fundamentals.

![](https://pbs.twimg.com/media/GpMRtFGa4AIo5Hn.png)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1914893736628417018/c:line.svg)

**Related Topics**
[$225b](/topic/$225b)
[supported](/topic/supported)
[eps](/topic/eps)
[dip](/topic/dip)
[stocks](/topic/stocks)
[$isrg](/topic/$isrg)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/SergeyCYW/status/1914893736628417018)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

SergeyCYW Avatar Sergey @SergeyCYW on x 6351 followers Created: 2025-04-23 04:06:58 UTC

$ISRG Posts +28% Net Income Growth in Q1’25 — But Shares Dip Slightly Intuitive Surgical reported another strong quarter. Net Income climbed +28.2% YoY with Net Margin expanding to 31%, and EPS rose +27.2% YoY to $XXXX. Operating Income jumped +23.2%, supported by margin expansion to 26%, while EBITDA margin held at 31%, signaling durable profitability.

Revenue increased +19.1% YoY to $2.25B, led by +25.0% growth in System sales and a +24.5% YoY rise in Da Vinci placements, reflecting continued momentum in surgical adoption. Recurring revenue also climbed +18.9%, showing strength in platform retention.

Yet despite all of this, shares fell -XXX% post-earnings. Could it be concern around margin trends in Services?

While Product Gross Profit grew +19.3% YoY, Services margin contracted significantly by -XXXX PPs YoY, despite only modest +6.9% growth in Services Gross Profit. That could signal pressure in high-margin service activities.

Valuation remains elevated with EV/Sales at XXXX and Forward P/E at XXXX. With expectations this high, even a strong quarter might not be enough to drive upside without a beat or guidance raise.

Operationally, $ISRG is executing well. The question is whether market sentiment can keep pace with fundamentals.

XXXXX engagements

Engagements Line Chart

Related Topics $225b supported eps dip stocks $isrg stocks healthcare

Post Link

post/tweet::1914893736628417018
/post/tweet::1914893736628417018